NEW YORK (Reuters) - A setback for Merck & Co's key cancer drug sent the drugmaker's stock swooning on Monday for a second straight session, putting the shares on track for their biggest two-day decline in more than eight years.
from Reuters: Business News http://ift.tt/2xyJsVx
from Reuters: Business News http://ift.tt/2xyJsVx
Cancer-drug setback sends Merck shares down again
![Cancer-drug setback sends Merck shares down again]()
Reviewed by Tha Kur
on
October 30, 2017
Rating:
No comments: